HYNIC-PSMA

P009
Grade:
GMP product
Tested for sterility and bacterial endotoxins
Description:
HYNIC-PSMA is a PSMA-based ligand that can bind radioactive metal ions and is used as a tumor-imaging agent in prostate cancer.
⁹⁹ᵐTc-HYNIC-PSMA is a novel Technetium-99m-labeled small-molecule inhibitor of prostate-specific membrane antigen (PSMA) for the detection of prostate cancer.
⁹⁹ᵐTc-HYNIC-PSMA showed high tracer uptake (tumor-to-background ratio: 9.42 ± 2.62) in malignant lesions of prostate cancer patients.
Molar weight:
567.59 g/mol (net substance)
Molecular formula:
C₂₄H₃₇N₇O₉ (net substance)
CAS №:
2213408-17-2
Retest date:
Not less than 18 months from the manufacturing date
Packaging:
2R/4ml or 8R/10ml Type I glass vials with bromobutyl rubber stoppers
Storage conditions:
–20 ±5 °C
Transportation at 2–8 °C (less than 1 month)
Available quantities:
0.1 mg; 1.0 mg; custom quantity upon request
Quality parameters

Quality parameters

Appearance: White solid
Identification:
– HPLC: Retention time of main peak corresponds to the HYNIC-PSMA reference standard
– Mass spectrometry: m/z = 567.6 ± 4
Residual heavy metals (ICP-OES): ≤ 100 ppm
Purity (HPLC): ≥ 98.0%
Bacterial endotoxins (gel-clot method): ≤ 10.0 EU/vial
Sterility (direct inoculation method): Sterile (passes test)
Sterility tests are performed for sterile products, made in aseptic conditions (class A).
Other products